Text Size
37 studies found for:    Open Studies | "Vitamin K"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Vitamin K as Additive Treatment in Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Phylloquinone;   Drug: Menaquinone (MK4);   Drug: placebo
2 Recruiting Vitamin K2 Intervention in Patients With Vitamin K Antagonists
Condition: Thrombosis
Intervention: Dietary Supplement: Vitamin K2
3 Recruiting The Effects of Vitamin K2 Supplementation on the Progression of Coronary Artery Calcification
Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Menaquinone-7 (Vitamin K2);   Other: Placebo capsules
4 Unknown † Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
Condition: Folliculitis
Intervention: Other: Vitamin K3
5 Unknown † Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
Conditions: Kidney Diseases;   Coronary Artery Calcification
Interventions: Drug: Vitamin K2+10μg cholecalciferol;   Drug: Vitamin D
6 Recruiting Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?
Conditions: Coagulation;   Bleeding;   Thrombosis
Interventions: Drug: Phytonadione (Vitamin K1);   Drug: Placebo
7 Recruiting Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1;   Drug: Chrystalline Lactose
8 Recruiting Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
Condition: Vitamin K1 to Slow the Progression of Thoracic Aortic and Coronary Artery Calcification
Intervention: Drug: Vitamin K1
9 Recruiting Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification
Condition: Aortic Valve Calcification
Intervention: Dietary Supplement: Vitamin K supplementation
10 Recruiting A Study Exploring Two Strategies of Rivaroxaban and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
11 Unknown † Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery
Conditions: Bleeding;   Complications
Intervention: Drug: Phytonadione
12 Recruiting A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
Condition: Atrial Fibrillation
Interventions: Drug: rivaroxaban;   Drug: uninterrupted vitamin K antagonist (VKA)
13 Recruiting Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Vitamin K antagonist (VKA)
14 Not yet recruiting Assessing the Effect of a Novel Combination Natural Therapy on Bone Health and Quality of Life in Osteopenic Women
Conditions: Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Fiber pill;   Drug: Strontium citrate/melatonin/Vitamins K2 and D3
15 Recruiting Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
Conditions: Venous Thromboembolism;   Neoplasms
Interventions: Drug: low molecular weight heparin;   Drug: vitamin K antagonists
16 Recruiting A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: Sirukumab;   Drug: Midazolam;   Drug: Warfarin;   Drug: Vitamin K;   Drug: Omeprazole;   Drug: Caffeine
17 Recruiting Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
Condition: Solid Tumors
Interventions: Drug: tivantinib;   Drug: omeprazole;   Drug: s-warfarin;   Drug: caffeine;   Dietary Supplement: vitamin K;   Drug: digoxin;   Drug: midazolam
18 Unknown † Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream
Condition: Metastatic Colorectal Cancer
Interventions: Device: Reconval K1 Cream;   Device: Reconval Cream
19 Recruiting Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
20 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
To Top

Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results
† Indicates status has not been verified in more than two years